Notably, PSTK was found to suppress ferroptosis induction in HCC cells in response to chemotherapy, whereas its depletion led to the inactivation of glutathione peroxidase 4 (GPX4) and glutathione metabolism, ultimately elevating ferroptosis induction upon targeted chemotherapy treatment. The gene discussed is PSTK; the disease is hepatocellular carcinoma.